Profile: Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. Our noninvasive technologies revolutionizing patient monitoring are Masimo SET® pulse oximetry, and Masimo Rainbow SET® Pulse CO-Oximetry. Our Masimo Rainbow SET Pulse CO-Oximetry is a breakthrough noninvasive blood constituent monitoring platform that measures many blood constituents that previously required invasive procedures. It continuously & noninvasively measures total hemoglobin (SpHb™), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®) and PVI™, oxyhemoglobin (SpO2), pulse rate (PR), & perfusion index (PI), enabling early detection & treatment of potentially life-threatening conditions. Our Masimo SET virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events.

The company was founded in 1989, has revenues of USD 50-100 Million, has ~1000 employees and is CE certified. NASDAQ:MASI (SEC Filings)

FDA Registration Number: 2031172